Molecular Immunology2022,Vol.14410.DOI:10.1016/j.molimm.2022.02.005

Expression of Id3 represses exhaustion of anti-tumor CD8 T cells in liver cancer

Jin, Yun Hu, Pingping Sun, Haihang Yang, Chao Zhai, Jianxin Wang, Yi Chu, Xinyun Sun, Zhiwei Wang, Jia Sun, Jie Wang, Junfeng
Molecular Immunology2022,Vol.14410.DOI:10.1016/j.molimm.2022.02.005

Expression of Id3 represses exhaustion of anti-tumor CD8 T cells in liver cancer

Jin, Yun 1Hu, Pingping 2Sun, Haihang 3Yang, Chao 1Zhai, Jianxin 1Wang, Yi 1Chu, Xinyun 1Sun, Zhiwei 1Wang, Jia 3Sun, Jie 4Wang, Junfeng1
扫码查看

作者信息

  • 1. Dept Hepatobiliary Surg,First Peoples Hosp Yunnan Prov
  • 2. Res Ctr Digital Med,First Peoples Hosp Yunnan Prov
  • 3. Linbing Biotechnol Ctr
  • 4. Dept Emergency & Crit Care Med,Shanghai Pudong New Area Peoples Hosp
  • 折叠

Abstract

Id3, an inhibitor of DNA binding protein, plays important roles in the function and homeostasis of effector and memory T cells. Recent evidence has shown that Id3 is also implicated in CD8 T cell exhaustion. However, whether and how Id3 might regulate effector function or exhaustion of CD8 T cells, especially in the tumor setting, is still unknown. Here, we first showed that Id3 expression was impaired in tumor-infiltrating CD8 T cells as liver cancer progressed, especially in PD-1+Tim-3 + exhausted CD8 T cells. Enforced expression of Id3 in CD8 T cells resulted in repressed development of anti-tumor CTLs exhaustion, which offered better tumor control. And partially depletion of Id3 in CD8 T cells promoted the development of exhausted CD8 T cells. Furthermore, Id3hi CD8 T cells could respond to PD-1 blockade. Collectively, Id3 exerts protective functions in CD8 T cells for liver cancer.

Key words

Id3/CD8 exhaustion/PD-1 blockade/Liver cancer/LIMITS/PD-1/E2A

引用本文复制引用

出版年

2022
Molecular Immunology

Molecular Immunology

ISTP
ISSN:0161-5890
被引量2
参考文献量27
段落导航相关论文